Trademark: 87158961
Word
ALLELE
Status
Dead
Status Code
606
Status Date
Monday, October 22, 2018
Serial Number
87158961
Mark Type
4000
Filing Date
Thursday, September 1, 2016
Published for Opposition
Tuesday, July 25, 2017
Abandoned Date
Monday, October 22, 2018

Trademark Owner History
Atara Biotherapeutics, Inc. - Owner At Publication

Classifications
42 Developing pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical trials of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical research of the effectiveness of pharmaceutical and therapeutic preparations, namely, by conducting clinical trial on patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD)

Trademark Events
Oct 22, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 22, 2018
Abandonment - No Use Statement Filed
Feb 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2018
Extension 1 Granted
Feb 20, 2018
Extension 1 Filed
Feb 20, 2018
Teas Extension Received
Sep 19, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 25, 2017
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2017
Published For Opposition
Jul 5, 2017
Notification Of Notice Of Publication E-Mailed
Jun 14, 2017
Approved For Pub - Principal Register
Jun 13, 2017
Teas/Email Correspondence Entered
Jun 12, 2017
Correspondence Received In Law Office
Jun 12, 2017
Teas Response To Office Action Received
Dec 12, 2016
Notification Of Non-Final Action E-Mailed
Dec 12, 2016
Non-Final Action E-Mailed
Dec 12, 2016
Non-Final Action Written
Dec 10, 2016
Assigned To Examiner
Sep 8, 2016
New Application Office Supplied Data Entered In Tram
Sep 5, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24